HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-DEC-20 7L5P TITLE CRYSTAL STRUCTURE OF THE COVALENTLY BONDED COMPLEX OF RILZABRUTINIB TITLE 2 WITH BTK COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE, ATK, B-CELL PROGENITOR COMPND 6 KINASE, BPK, BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PROTEIN KINASE INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.BRADSHAW,K.A.BRAMELD,M.MROSEK,A.LAMMENS,M.BLAESSE REVDAT 2 03-APR-24 7L5P 1 REMARK REVDAT 1 29-JUN-22 7L5P 0 JRNL AUTH T.D.OWENS JRNL TITL THE DISCOVERY RILZABRUTINIB (PRN1008): A REVERSIBLE COVALENT JRNL TITL 2 BTK INHIBITOR FOR IMMUNE MEDIATED DISEASES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 87.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 29411 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1569 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.20 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2204 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.62 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE SET COUNT : 130 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4378 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 121 REMARK 3 SOLVENT ATOMS : 220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.45000 REMARK 3 B22 (A**2) : 1.31000 REMARK 3 B33 (A**2) : -0.74000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.43000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.323 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.226 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.182 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.129 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4540 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4202 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6161 ; 1.458 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9643 ; 2.625 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 546 ; 5.354 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 196 ;33.777 ;23.673 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 765 ;13.570 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;12.508 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 660 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5048 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1061 ; 0.008 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7L5P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1000252259. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : 6-7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00001 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30980 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 87.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 2.890 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.43700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.710 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PREVIOUSLY SOLVED STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 5000 MME AMMONIUM SULFATE MES, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.34200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 389 REMARK 465 LEU A 390 REMARK 465 GLY A 391 REMARK 465 GLY B 389 REMARK 465 LEU B 390 REMARK 465 GLY B 391 REMARK 465 TYR B 392 REMARK 465 SER B 659 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 400 CD CE NZ REMARK 480 LYS A 406 CD CE NZ REMARK 480 LYS A 417 NZ REMARK 480 GLN A 424 CG CD OE1 NE2 REMARK 480 LYS A 433 CG CD CE NZ REMARK 480 GLU A 434 CG CD OE1 OE2 REMARK 480 MET A 437 CE REMARK 480 GLU A 439 CG CD OE1 OE2 REMARK 480 ASP A 440 CG OD1 OD2 REMARK 480 PHE A 442 CG CD1 CD2 CE1 CE2 CZ REMARK 480 GLU A 445 CG CD OE1 OE2 REMARK 480 LYS A 447 NZ REMARK 480 LYS A 466 CD CE NZ REMARK 480 GLN A 496 CG CD OE1 NE2 REMARK 480 GLN A 516 CD OE1 NE2 REMARK 480 ARG A 544 NE CZ NH1 NH2 REMARK 480 LEU A 547 CG CD1 CD2 REMARK 480 ASP A 549 CG OD1 OD2 REMARK 480 THR A 552 OG1 CG2 REMARK 480 LYS A 558 CG CD CE NZ REMARK 480 LYS A 573 CE NZ REMARK 480 GLU A 624 CD OE1 OE2 REMARK 480 GLU A 636 CD OE1 OE2 REMARK 480 LYS A 637 CD CE NZ REMARK 480 GLU B 396 CD OE1 OE2 REMARK 480 LYS B 400 CD CE NZ REMARK 480 LYS B 406 CD CE NZ REMARK 480 GLN B 412 CG CD OE1 NE2 REMARK 480 GLN B 424 CD OE1 NE2 REMARK 480 TYR B 425 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 LYS B 433 CG CD CE NZ REMARK 480 GLU B 434 CG CD OE1 OE2 REMARK 480 GLU B 441 CG CD OE1 OE2 REMARK 480 LYS B 466 CE NZ REMARK 480 ARG B 468 CZ NH1 NH2 REMARK 480 ARG B 490 CD NE CZ NH1 NH2 REMARK 480 HIS B 491 CG ND1 CD2 CE1 NE2 REMARK 480 ARG B 492 CG CD NE CZ NH1 NH2 REMARK 480 ASP B 549 CG OD1 OD2 REMARK 480 LYS B 558 CD CE NZ REMARK 480 LYS B 573 CE NZ REMARK 480 LYS B 625 CE NZ REMARK 480 ASP B 656 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 424 -52.77 -127.06 REMARK 500 ARG A 520 -4.37 77.95 REMARK 500 ARG A 520 -1.66 77.07 REMARK 500 ASP A 521 47.39 -162.32 REMARK 500 ASP A 521 47.39 -163.46 REMARK 500 TRP B 395 -82.23 -123.96 REMARK 500 GLN B 424 -53.63 -131.29 REMARK 500 ARG B 520 -11.20 83.16 REMARK 500 ASP B 521 47.09 -156.97 REMARK 500 REMARK 500 REMARK: NULL DBREF 7L5P A 389 659 UNP Q06187 BTK_HUMAN 389 659 DBREF 7L5P B 389 659 UNP Q06187 BTK_HUMAN 389 659 SEQRES 1 A 271 GLY LEU GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP SEQRES 2 A 271 LEU THR PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY SEQRES 3 A 271 VAL VAL LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL SEQRES 4 A 271 ALA ILE LYS MET ILE LYS GLU GLY SER MET SER GLU ASP SEQRES 5 A 271 GLU PHE ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER SEQRES 6 A 271 HIS GLU LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS SEQRES 7 A 271 GLN ARG PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN SEQRES 8 A 271 GLY CYS LEU LEU ASN TYR LEU ARG GLU MET ARG HIS ARG SEQRES 9 A 271 PHE GLN THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL SEQRES 10 A 271 CYS GLU ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU SEQRES 11 A 271 HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP SEQRES 12 A 271 GLN GLY VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG SEQRES 13 A 271 TYR VAL LEU ASP ASP GLU TYR THR SER SER VAL GLY SER SEQRES 14 A 271 LYS PHE PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET SEQRES 15 A 271 TYR SER LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE SEQRES 16 A 271 GLY VAL LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET SEQRES 17 A 271 PRO TYR GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS SEQRES 18 A 271 ILE ALA GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SEQRES 19 A 271 SER GLU LYS VAL TYR THR ILE MET TYR SER CYS TRP HIS SEQRES 20 A 271 GLU LYS ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SEQRES 21 A 271 SER ASN ILE LEU ASP VAL MET ASP GLU GLU SER SEQRES 1 B 271 GLY LEU GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP SEQRES 2 B 271 LEU THR PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY SEQRES 3 B 271 VAL VAL LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL SEQRES 4 B 271 ALA ILE LYS MET ILE LYS GLU GLY SER MET SER GLU ASP SEQRES 5 B 271 GLU PHE ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER SEQRES 6 B 271 HIS GLU LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS SEQRES 7 B 271 GLN ARG PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN SEQRES 8 B 271 GLY CYS LEU LEU ASN TYR LEU ARG GLU MET ARG HIS ARG SEQRES 9 B 271 PHE GLN THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL SEQRES 10 B 271 CYS GLU ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU SEQRES 11 B 271 HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP SEQRES 12 B 271 GLN GLY VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG SEQRES 13 B 271 TYR VAL LEU ASP ASP GLU TYR THR SER SER VAL GLY SER SEQRES 14 B 271 LYS PHE PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET SEQRES 15 B 271 TYR SER LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE SEQRES 16 B 271 GLY VAL LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET SEQRES 17 B 271 PRO TYR GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS SEQRES 18 B 271 ILE ALA GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SEQRES 19 B 271 SER GLU LYS VAL TYR THR ILE MET TYR SER CYS TRP HIS SEQRES 20 B 271 GLU LYS ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SEQRES 21 B 271 SER ASN ILE LEU ASP VAL MET ASP GLU GLU SER HET R1L A 701 49 HET SO4 A 702 5 HET SO4 A 703 5 HET R1L B 701 49 HET EDO B 702 4 HET EDO B 703 4 HET SO4 B 704 5 HETNAM R1L (2E)-2-{(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXYPHENYL)- HETNAM 2 R1L 1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1- HETNAM 3 R1L CARBONYL}-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1- HETNAM 4 R1L YL]PENT-2-ENENITRILE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN R1L RILZABRUTINIB HETSYN EDO ETHYLENE GLYCOL FORMUL 3 R1L 2(C36 H40 F N9 O3) FORMUL 4 SO4 3(O4 S 2-) FORMUL 7 EDO 2(C2 H6 O2) FORMUL 10 HOH *220(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 LEU A 452 1 15 HELIX 3 AA3 CYS A 481 GLU A 488 1 8 HELIX 4 AA4 GLN A 494 LYS A 515 1 22 HELIX 5 AA5 ASP A 548 SER A 553 1 6 HELIX 6 AA6 PRO A 560 SER A 564 5 5 HELIX 7 AA7 PRO A 565 SER A 572 1 8 HELIX 8 AA8 SER A 575 SER A 592 1 18 HELIX 9 AA9 THR A 602 GLN A 612 1 11 HELIX 10 AB1 SER A 623 CYS A 633 1 11 HELIX 11 AB2 LYS A 637 ARG A 641 5 5 HELIX 12 AB3 THR A 643 SER A 659 1 17 HELIX 13 AB4 ASP B 398 LYS B 400 5 3 HELIX 14 AB5 SER B 438 LEU B 452 1 15 HELIX 15 AB6 LEU B 482 MET B 489 1 8 HELIX 16 AB7 GLN B 494 LYS B 515 1 22 HELIX 17 AB8 ASP B 548 SER B 553 1 6 HELIX 18 AB9 PRO B 560 SER B 564 5 5 HELIX 19 AC1 PRO B 565 SER B 572 1 8 HELIX 20 AC2 SER B 575 SER B 592 1 18 HELIX 21 AC3 THR B 602 GLN B 612 1 11 HELIX 22 AC4 SER B 623 CYS B 633 1 11 HELIX 23 AC5 LYS B 637 ARG B 641 5 5 HELIX 24 AC6 THR B 643 GLU B 658 1 16 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O GLY A 414 N GLY A 411 SHEET 3 AA1 5 TYR A 425 ILE A 432 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 ILE A 470 GLU A 475 -1 O ILE A 470 N ILE A 432 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 2 LEU A 528 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 LYS A 536 -1 O LYS A 536 N LEU A 528 SHEET 1 AA3 5 LEU B 402 GLY B 411 0 SHEET 2 AA3 5 GLY B 414 TRP B 421 -1 O TYR B 418 N LYS B 406 SHEET 3 AA3 5 TYR B 425 ILE B 432 -1 O MET B 431 N VAL B 415 SHEET 4 AA3 5 PHE B 471 THR B 474 -1 O THR B 474 N ALA B 428 SHEET 5 AA3 5 LEU B 460 CYS B 464 -1 N TYR B 461 O ILE B 473 SHEET 1 AA4 3 GLY B 480 CYS B 481 0 SHEET 2 AA4 3 LEU B 528 VAL B 529 -1 O VAL B 529 N GLY B 480 SHEET 3 AA4 3 VAL B 535 LYS B 536 -1 O LYS B 536 N LEU B 528 LINK SG CYS A 481 C37 R1L A 701 1555 1555 1.77 LINK SG CYS B 481 C37 R1L B 701 1555 1555 1.80 CISPEP 1 ARG A 468 PRO A 469 0 -1.36 CISPEP 2 ARG B 468 PRO B 469 0 1.66 CRYST1 43.810 76.684 88.321 90.00 96.46 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022826 0.000000 0.002584 0.00000 SCALE2 0.000000 0.013041 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011395 0.00000